Corporate news

Grifols refinances debt for USD 6.3 billion, reducing the margin to 200 bps and extending its maturities The company has concluded its debt refinancing process substantially improving all conditions
+ info

Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million The company consolidates a leading position of its Diagnostic Division enhancing its integration
+ info



We are a solid company with an international dimension.

Corporate Commitment

We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.

When a Dream Comes True. An Illustrated History of 75 Years of Grifols

Read When a Dream Comes True: An illustrated history of 75 years of Grifols to discover the company's roots, and learn more about our history and the development of the company.  + info


get to know us better